Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery

Clinical trial NCT02336087 · ACTIVE_NOT_RECRUITING

Trial details

NCT number

NCT02336087

Sponsor

City of Hope Medical Center

Status

ACTIVE_NOT_RECRUITING

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2016-01-14

Primary completion

2020-10-04

Enrollment

21

View on ClinicalTrials.gov